Juan José Andrés Lencina

<i>TERT</i> promoter mutation subtypes and survival in stage I and II melanoma patients

Juan José Andrés Lencina, P. Sivaramakrishna Rachakonda, Zaida García‐Casado et al. · International Journal of Cancer · 2018 · 54 citations

Medicine, Genetics, Oncology +12

Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study

Alicia Barreiro, Juan José Andrés Lencina, Sebastián Podlipnik et al. · European Journal of Cancer · 2021 · 17 citations

Medicine, Dermatology, Oncology +15

Behçet’s‐like disease during secukinumab treatment: new paradoxical reaction?

Alba Calleja‐Algarra, Raquel Aragón Miguel, Juan José Andrés Lencina et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2020 · 16 citations

Life Sciences, Immunology, Pharmacotherapy +9

[Translated article] Practical Update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis with Biologic Therapy. Part 1. Concepts and General Management of Psoriasis With Biologic Therapy

J.M. Carrascosa, L. Puig, I. Belinchón et al. · Actas Dermo-Sifiliográficas · 2022 · 12 citations · Full text

Medicine, Dermatology, Pharmacotherapy +12

Mesotherapy with Bicalutamide

Alba Gómez‐Zubiaur, Juan José Andrés Lencina, Víctor Cabezas et al. · International Journal of Trichology · 2023 · 11 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +13